Annual report
6942.TEDINET S100R6YI
Period2022-04-01 → 2023-03-31
Filed2023-06-28
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 143
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥9.4bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales |
| Revenue | ¥11.8bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales |
| Revenue | ¥11.4bn | 2020-04-01 → 2021-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥9.8bn | 2019-04-01 → 2020-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥4.5bn | 2018-04-01 → 2019-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥369m | 2022-04-01 → 2023-03-31 | Cons. | Operating income |
| Operating income | ¥883m | 2021-04-01 → 2022-03-31 | Cons. | Operating income |
| Ordinary income | ¥399m | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥889m | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥749m | 2020-04-01 → 2021-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥156m | 2019-04-01 → 2020-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥343m | 2018-04-01 → 2019-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥231m | 2022-04-01 → 2023-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥875m | 2021-04-01 → 2022-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥21m | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥613m | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥502m | 2020-04-01 → 2021-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥160m | 2019-04-01 → 2020-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥391m | 2018-04-01 → 2019-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥21m | 2022-04-01 → 2023-03-31 | Cons. | Profit loss |
| Net income | ¥613m | 2021-04-01 → 2022-03-31 | Cons. | Profit loss |
| Total assets | ¥7.4bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥8.6bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥8.6bn | at 2021-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥8.9bn | at 2020-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥6.8bn | at 2019-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥5.4bn | at 2023-03-31 | Cons. | Liabilities |
| Total liabilities | ¥6.6bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥2.0bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥2.0bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥1.4bn | at 2021-03-31d | Cons. | Net assets |
| Net assets / equity | ¥884m | at 2020-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥724m | at 2019-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥2.0bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥2.3bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥2.0bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.3bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.1bn | at 2021-03-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.6bn | at 2020-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥2.7bn | at 2019-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥411m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.1bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.2bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥83m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥534m | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥39m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥151m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | ¥86m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥328m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1.6bn | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥694m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥696m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥793m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥717m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥3.1bn | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥7.85 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥228.11 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥186.65 | 2020-04-01 → 2021-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥59.34 | 2019-04-01 → 2020-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-161.78 | 2018-04-01 → 2019-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥753.48 | at 2023-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥745.63 | at 2022-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥515.39 | at 2021-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥328.63 | at 2020-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥269.25 | at 2019-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 27.4% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 23.3% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 16.1% | at 2021-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 9.9% | at 2020-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 10.6% | at 2019-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 1.0% | 2022-04-01 → 2023-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 36.2% | 2021-04-01 → 2022-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 44.2% | 2020-04-01 → 2021-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 19.8% | 2019-04-01 → 2020-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | -58.3% | 2018-04-01 → 2019-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 215 | at 2023-03-31 | Cons. | Number of employees |
| Employees | 209 | at 2022-03-31 | Cons. | Number of employees |
| Employees | 228 | at 2021-03-31d | Cons. | Number of employees |
| Employees | 230 | at 2020-03-31d | Cons. | Number of employees |
| Employees | 122 | at 2019-03-31d | Cons. | Number of employees |
| Revenue | ¥427m | 2022-04-01 → 2023-03-31 | Standalone | Operating revenue1 |
| Revenue | ¥395m | 2021-04-01 → 2022-03-31 | Standalone | Operating revenue1 |
| Revenue | ¥310m | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥213m | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥398m | 2018-04-01 → 2019-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥123m | 2022-04-01 → 2023-03-31 | Standalone | Operating income |
| Operating income | ¥45m | 2021-04-01 → 2022-03-31 | Standalone | Operating income |
| Ordinary income | ¥106m | 2022-04-01 → 2023-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥115m | 2021-04-01 → 2022-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥76m | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥410m | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥160m | 2018-04-01 → 2019-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥37m | 2022-04-01 → 2023-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥93m | 2021-04-01 → 2022-03-31 | Standalone | Income before income taxes |
| Net income | ¥56m | 2022-04-01 → 2023-03-31 | Standalone | Profit loss |
| Net income | ¥149m | 2021-04-01 → 2022-03-31 | Standalone | Profit loss |
| Net income | ¥216m | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | −¥262m | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | −¥161m | 2018-04-01 → 2019-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥2.5bn | at 2023-03-31 | Standalone | Assets |
| Total assets | ¥3.0bn | at 2022-03-31 | Standalone | Assets |
| Total assets | ¥3.6bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥3.4bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥4.2bn | at 2019-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥1.7bn | at 2023-03-31 | Standalone | Liabilities |
| Total liabilities | ¥2.2bn | at 2022-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥828m | at 2023-03-31 | Standalone | Net assets |
| Net assets / equity | ¥772m | at 2022-03-31 | Standalone | Net assets |
| Net assets / equity | ¥623m | at 2021-03-31d | Standalone | Net assets |
| Net assets / equity | ¥408m | at 2020-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥670m | at 2019-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥207m | at 2023-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥155m | at 2022-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥20.77 | 2022-04-01 → 2023-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥55.25 | 2021-04-01 → 2022-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥80.15 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-97.26 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-66.58 | 2018-04-01 → 2019-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥307.86 | at 2023-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥287.1 | at 2022-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥231.85 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥151.74 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥249.02 | at 2019-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 32.5% | at 2023-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 26.1% | at 2022-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 17.5% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 12.1% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 15.9% | at 2019-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 7.0% | 2022-04-01 → 2023-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 21.3% | 2021-04-01 → 2022-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 41.8% | 2020-04-01 → 2021-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | -48.5% | 2019-04-01 → 2020-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | -32.2% | 2018-04-01 → 2019-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 2,737,000 | at 2023-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 2,737,000 | at 2022-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 2,737,000 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 2,737,000 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 2,737,000 | at 2019-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 10 | at 2023-03-31 | Standalone | Number of employees |
| Employees | 9 | at 2022-03-31 | Standalone | Number of employees |
| Employees | 10 | at 2021-03-31d | Standalone | Number of employees |
| Employees | 11 | at 2020-03-31d | Standalone | Number of employees |
| Employees | 9 | at 2019-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 67
| Segment | Item | Period | Value |
|---|---|---|---|
| Dispensing Pharmacy And Related Businessreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥25m |
| Dispensing Pharmacy And Related Businessreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥56m |
| Dispensing Pharmacy And Related Businessreportable segment | employees | at 2023-03-31 | 149 pure |
| Dispensing Pharmacy And Related Businessreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥6.9bn |
| Dispensing Pharmacy And Related Businessreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥6.9bn |
| Dispensing Pharmacy And Related Businessreportable segment | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥9m |
| Dispensing Pharmacy And Related Businessreportable segment | segment assets | at 2023-03-31 | ¥5.8bn |
| Dispensing Pharmacy And Related Businessreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥280m |
| Internet Related Businessreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥2m |
| Internet Related Businessreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥2m |
| Internet Related Businessreportable segment | employees | at 2023-03-31 | 47 pure |
| Internet Related Businessreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥1.6bn |
| Internet Related Businessreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥1.6bn |
| Internet Related Businessreportable segment | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥9m |
| Internet Related Businessreportable segment | segment assets | at 2023-03-31 | ¥1.3bn |
| Internet Related Businessreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥138m |
| Telecommunications Businessreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥355,000 |
| Telecommunications Businessreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥2m |
| Telecommunications Businessreportable segment | employees | at 2023-03-31 | 9 pure |
| Telecommunications Businessreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥984m |
| Telecommunications Businessreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥980m |
| Telecommunications Businessreportable segment | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥4m |
| Telecommunications Businessreportable segment | segment assets | at 2023-03-31 | ¥643m |
| Telecommunications Businessreportable segment | segment profit | 2022-04-01 → 2023-03-31 | −¥22m |
| Total Of Reportable Segments And Otherssegment total | capex | 2022-04-01 → 2023-03-31 | ¥27m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2022-04-01 → 2023-03-31 | ¥61m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2023-03-31 | ¥9.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2023-03-31 | ¥9.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥22m |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2023-03-31 | ¥7.7bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2023-03-31 | ¥396m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-04-01 → 2022-03-31 | −¥203,000 |
| Dispensing Pharmacy And Related Businessreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥145m |
| Dispensing Pharmacy And Related Businessreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥53m |
| Dispensing Pharmacy And Related Businessreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥7.0bn |
| Dispensing Pharmacy And Related Businessreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥7.0bn |
| Dispensing Pharmacy And Related Businessreportable segment | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥9m |
| Dispensing Pharmacy And Related Businessreportable segment | segment assets | at 2022-03-31 | ¥6.0bn |
| Dispensing Pharmacy And Related Businessreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥390m |
| Internet Related Businessreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥6m |
| Internet Related Businessreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥2m |
| Internet Related Businessreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥1.2bn |
| Internet Related Businessreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥1.2bn |
| Internet Related Businessreportable segment | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥17m |
| Internet Related Businessreportable segment | segment assets | at 2022-03-31 | ¥1.2bn |
| Internet Related Businessreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥121m |
| Telecommunications Businessreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥4m |
| Telecommunications Businessreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥2m |
| Telecommunications Businessreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥3.6bn |
| Telecommunications Businessreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥3.6bn |
| Telecommunications Businessreportable segment | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥30m |
| Telecommunications Businessreportable segment | segment assets | at 2022-03-31 | ¥1.6bn |
| Telecommunications Businessreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥484m |
| —segment total | capex | 2021-04-01 → 2022-03-31 | ¥156m |
| —segment total | depreciation | 2021-04-01 → 2022-03-31 | ¥58m |
| —segment total | revenue | 2021-04-01 → 2022-03-31 | ¥11.8bn |
| —segment total | revenue external | 2021-04-01 → 2022-03-31 | ¥11.8bn |
| —segment total | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥56m |
| —segment total | segment assets | at 2022-03-31 | ¥8.8bn |
| —segment total | segment profit | 2021-04-01 → 2022-03-31 | ¥995m |
| Total Of Reportable Segments And Otherssegment total | capex | 2021-04-01 → 2022-03-31 | ¥156m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2021-04-01 → 2022-03-31 | ¥58m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2022-03-31 | ¥11.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2022-03-31 | ¥11.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥56m |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2022-03-31 | ¥8.8bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2022-03-31 | ¥995m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,290
| Item | Context | Value | Unit |
|---|---|---|---|
| Total shareholder return | Prior3YearInstant_NonConsolidatedMember | 0.347 | |
| Total shareholder return | Prior2YearInstant_NonConsolidatedMember | 0.997 | |
| Total shareholder return | Prior1YearInstant_NonConsolidatedMember | 0.685 | |
| Total shareholder return | CurrentYearInstant_NonConsolidatedMember | 0.503 | |
| Total return on share price index | Prior4YearInstant_NonConsolidatedMember | 0.950 | |
| Total return on share price index | Prior3YearInstant_NonConsolidatedMember | 0.859 | |
| Total return on share price index | Prior2YearInstant_NonConsolidatedMember | 1.221 | |
| Total return on share price index | Prior1YearInstant_NonConsolidatedMember | 1.246 | |
| Total return on share price index | CurrentYearInstant_NonConsolidatedMember | 1.318 | |
| Number of employees | CurrentYearInstant_jpcrp030000-asr_E01978-000InternetRelatedBusinessReportableSegmentsMember | 47 | |
| Average number of temporary workers | CurrentYearInstant_jpcrp030000-asr_E01978-000InternetRelatedBusinessReportableSegmentsMember | 18 | |
| Number of employees | CurrentYearInstant_jpcrp030000-asr_E01978-000TelecommunicationsBusinessReportableSegmentsMember | 9 | |
| Average number of temporary workers | CurrentYearInstant_jpcrp030000-asr_E01978-000TelecommunicationsBusinessReportableSegmentsMember | 1 | |
| Number of employees | CurrentYearInstant_jpcrp030000-asr_E01978-000DispensingPharmacyAndRelatedBusinessReportableSegmentMember | 149 | |
| Average number of temporary workers | CurrentYearInstant_jpcrp030000-asr_E01978-000DispensingPharmacyAndRelatedBusinessReportableSegmentMember | 60 | |
| Number of employees | CurrentYearInstant_CorporateSharedMember | 10 | |
| Average number of temporary workers | CurrentYearInstant_CorporateSharedMember | 2 | |
| Number of employees | CurrentYearInstant | 215 | |
| Average number of temporary workers | CurrentYearInstant | 81 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember | 10 | |
| Average number of temporary workers | CurrentYearInstant_NonConsolidatedMember | 2 | |
| Average age years information about reporting company information about employees | CurrentYearInstant_NonConsolidatedMember | 39 | |
| Average age months information about reporting company information about employees | CurrentYearInstant_NonConsolidatedMember | 7 | |
| Average length of service years information about reporting company information about employees | CurrentYearInstant_NonConsolidatedMember | 2 | |
| Average length of service months information about reporting company information about employees | CurrentYearInstant_NonConsolidatedMember | 10 | |
| Average annual salary information about reporting company information about employees | CurrentYearInstant_NonConsolidatedMember | 5089017 | JPY |
| Research and development expenses research and development activities | CurrentYearDuration | 12842000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration | 27000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E01978-000InternetRelatedBusinessReportableSegmentsMember | 1000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E01978-000TelecommunicationsBusinessReportableSegmentsMember | 0 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E01978-000DispensingPharmacyAndRelatedBusinessReportableSegmentMember | 24000000 | JPY |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 2737720 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 2737720 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 2737720 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 2737720 | |
| Number of shares constituting one unit | CurrentYearInstant_OrdinaryShareMember | 100 | |
| Number of shareholders national and local governments | CurrentYearInstant_OrdinaryShareMember | － | |
| Number of shareholders financial institutions | CurrentYearInstant_OrdinaryShareMember | 1 | |
| Number of shareholders financial service providers | CurrentYearInstant_OrdinaryShareMember | 12 | |
| Number of shareholders other corporations | CurrentYearInstant_OrdinaryShareMember | 16 | |
| Number of shareholders foreign investors other than individuals | CurrentYearInstant_OrdinaryShareMember | 10 | |
| Number of shareholders foreign individual investors | CurrentYearInstant_OrdinaryShareMember | 4 | |
| Number of shareholders individuals and others | CurrentYearInstant_OrdinaryShareMember | 782 | |
| Number of shareholders total | CurrentYearInstant_OrdinaryShareMember | 825 | |
| Number of shares held number of units national and local governments | CurrentYearInstant_OrdinaryShareMember | － | |
| Number of shares held number of units financial institutions | CurrentYearInstant_OrdinaryShareMember | 524 | |
| Number of shares held number of units financial service providers | CurrentYearInstant_OrdinaryShareMember | 727 | |
| Number of shares held number of units other corporations | CurrentYearInstant_OrdinaryShareMember | 19552 | |
| Number of shares held number of units foreign investors other than individuals | CurrentYearInstant_OrdinaryShareMember | 99 | |
| Number of shares held number of units foreign individual investors | CurrentYearInstant_OrdinaryShareMember | 112 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |